Vanessa
Vanessa Almendro Navarro, Granollers ES
Patent application number | Description | Published |
---|---|---|
20110027296 | ANTIBODIES FOR TREATING CANCER - The invention relates to the use of an antibody or a fragment thereof, specific against substance P, for the manufacture of a medicament for therapeutic treatment of a cancer expressing NK1 receptor and/or a ErbB receptor family member (i.e. the epidermal growth factor receptors family), by direct administration to a mammal, including a human. The administration of an antibody against substance P to a panel of breast cancer cell lines, inhibits HER2 activation and expression, causing a downregulation of different genes involved in cell cycle progression, like cyclin D1, cyclin E, cdk4 and cdk2. A decrease in proliferation and an arrest in G | 02-03-2011 |
Vanessa Bobbe, Bonn DE
Patent application number | Description | Published |
---|---|---|
20130261708 | SUBSTITUTED TETRAARYLBENZENES - The present invention relates to substances, to electroluminescent device comprising these substances, and to the use thereof. | 10-03-2013 |
20130317475 | SUBSTITUTED DIBENZONAPHRACENES - The present invention relates to substances, to electroluminescent devices comprising these substances, and to the use thereof. | 11-28-2013 |
20150057445 | SUBSTITUTED TETRAARYLBENZENES - The present invention relates to substances, to electroluminescent device comprising these substances, and to the use thereof. | 02-26-2015 |
Vanessa Boner, Klosters CH
Patent application number | Description | Published |
---|---|---|
20080300603 | METHOD FOR PLACEMENT OF BONE CEMENT INTO PRE-SELECTED BONE REGIONS - A method for applying bone cement into a bone structure that includes the steps of: selecting at least one region in a bone where the trabecular bone structure is to be augmented, producing at least one cavity (20) communicating with said at least one bone region, applying a fluid jet lavage towards said at lest one bone region, and providing bone cement to said at least one bone region. | 12-04-2008 |
20100145277 | CANNULA - A cannula ( | 06-10-2010 |
Vanessa Bourgeaux, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100316620 | Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's Disease - The invention relates to the prevention and treatment of skeletal manifestation of Gaucher's disease. It relates to a formulation for introducing glucocerebrosidase into the lysosomal compartment of macrophages and/or Gaucher cells in the bone marrow, the formulation comprising glucocerebrosidase encapsulated in erythrocytes. Said erythrocytes may have been subjected to a chemical treatment with an agent so as to promote the targeting of macrophages and/or Gaucher cells in the bone marrow. The treatment may be carried out with a bis(sulphosuccinimidyl) suberate (BS3) solution. The invention also describes drugs and methods for prevention and treatment. | 12-16-2010 |
20110014171 | Formulation and Method for the Prevention and Treatment of Bone Metastases or Other Bone Diseases - The invention relates to a suspension of erythrocytes encapsulating a bisphosphonate, for use as a medicament for the prevention and treatment of bone metastases and other bone marrow diseases. It also relates to a suspension of erythrocytes encapsulating a bisphosphonate, in which these erythrocytes have undergone a chemical treatment with an agent such as BS3 so as to promote targeting of the bone marrow. | 01-20-2011 |
20120129210 | Method for Assaying Inositol Hexaphosphate (IHP) - The invention relates to a method for assaying inositol hexaphosphate (IHP) in a product that can be injected in humans or animals or in a fraction of this product, in which a metal compound is added to a sample or a fraction of this product and the complexation of said metal compound with the IHP present is subsequently detected, by virtue of which the IHP present in the product or fraction thereof is assayed. The invention makes it possible to assay the IHP in a suspension or a solution, and in particular in the various compartments of a suspension of red blood cells. | 05-24-2012 |
20140010795 | FORMULATION AND METHOD FOR THE PREVENTION AND TREATMENT OF BONE METASTASES OR OTHER BONE DISEASES - A suspension of erythrocytes encapsulating a bisphosphonate is provided along with a method for its use for the prevention and treatment of bone metastases and other bone marrow diseases. The suspension of erythrocytes encapsulating a bisphosphonate may also be provided in which the erythrocytes have undergone a chemical treatment with an agent such as BS3 so as to promote targeting of the bone marrow. The method for the prevention and treatment of bone metastases may be accomplished by administering to a patient in need thereof of a suspension of erythrocytes encapsulating a second-generation or a third-generation bisphosphonate. | 01-09-2014 |
20140363413 | FORMULATION AND METHOD FOR THE PREVENTION AND TREATMENT OF BONE METASTASES OR OTHER BONE DISEASES - A suspension of erythrocytes encapsulating a bisphosphonate is provided along with a method for its use for the prevention and treatment of bone metastases and other bone marrow diseases. The suspension of erythrocytes encapsulating a bisphosphonate may also be provided in which the erythrocytes have undergone a chemical treatment with an agent such as BS3 so as to promote targeting of the bone marrow. The method for the prevention and treatment of bone metastases may be accomplished by administering to a patient in need thereof of a suspension of erythrocytes encapsulating a second-generation or a third-generation bisphosphonate. | 12-11-2014 |
Vanessa Bres, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110269819 | METHODS AND COMPOSITIONS FOR TARGETING SKIP - Provided herein are methods and compositions for modulating apoptosis by targeting SKIP (Ski-interacting protein) activity. Methods of increasing DNA damage-induced cell death in cancer cells, and reducing DNA damage-induced cell death in normal cells are provided. | 11-03-2011 |
Vanessa Bruat, Ville St-Laurent CA
Patent application number | Description | Published |
---|---|---|
20100099083 | CROHN DISEASE SUSCEPTIBILITY GENE - The present invention relates to the ATG16l1 gene and genetic variants associated with Crohn's disease. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs. | 04-22-2010 |
Vanessa Bruat, Montreal CA
Patent application number | Description | Published |
---|---|---|
20100120628 | GENEMAP OF THE HUMAN GENES ASSOCIATED WITH ADHD - The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to ADHD disease and/or their response to a particular drug or drugs. | 05-13-2010 |
20100144538 | GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA - The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs. | 06-10-2010 |
Vanessa Capodieci, Muenchen DE
Patent application number | Description | Published |
---|---|---|
20140167043 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING A SEMICONDUCTOR DEVICE - A semiconductor device includes a semiconductor substrate including a main surface with a polygonal geometry and a main electric circuit manufactured within a main region on the semiconductor substrate. The main electric circuit is operable to perform an electric main function. The main region extends over the main surface of the semiconductor substrate leaving open at least one corner area at a corner of the polygonal geometry of the main surface of the semiconductor substrate. The corner area extends at least 300 μm along the edges of the semiconductor substrate beginning at the corner. | 06-19-2014 |
20140167044 | Semiconductor Device and Method for Manufacturing a Semiconductor Device - A semiconductor device includes a semiconductor substrate including a main surface with a polygonal geometry and a main electric circuit manufactured within a main region on the semiconductor substrate. The main electric circuit is operable to perform an electric main function. The main region extends over the main surface of the semiconductor substrate leaving open at least one corner area at a corner of the polygonal geometry of the main surface of the semiconductor substrate. The corner area extends at least 300 μm along the edges of the semiconductor substrate beginning at the corner. | 06-19-2014 |
Vanessa Chanteperdrix, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20120270249 | MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS - A method for distinguishing among a first group of microorganisms, belonging to a first taxon of bacteria that is vancomycin resistant; a second group of microorganisms, belonging to a second taxon of vancomycin resistant bacteria that is different than said first taxon; and a third group of microorganisms that is not resistant or has a natural resistance to vancomycin. | 10-25-2012 |
20120270252 | MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS - A method for distinguishing among a first group of microorganisms belonging to a first taxon of Gram negative bacteria, the first group of bacteria exhibiting a mechanism of resistance to a treatment; a second group of microorganisms belonging to a second taxon of Gram negative bacteria, the second taxon of bacteria being different than said first taxon, and exhibiting a mechanism of resistance to a treatment identical to the mechanism of the first group; and a third group of Gram negative bacteria that is not resistant to the treatment. | 10-25-2012 |
20120276566 | MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS - A method for distinguishing among a first group of microorganisms, belonging to a first taxon of yeasts that is resistant to an antifungal; a second group of microorganisms, belonging to a second taxon of yeasts that is different than the first taxon of yeasts, and that exhibits the mechanism of resistance to the antifungal exhibited by the first group; and a third group that is not resistant to the antifungal. | 11-01-2012 |
Vanessa Correa Arantes, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20130288051 | MECHANICAL AND ANTICORROSIVE PROTECTION VINYL TAPE - Pressure sensitive tape for anticorrosion steel pipe protection used primarily in cases of repair and maintenance, comprising vinyl base-tape laminated with a nitrile rubber-based adhesive of the following composition: about 30.7 to about 34.0% (w/w) solid butadiene acrylonitrile rubber (NBR); about 0.57 to about 0.63% (w/w) antioxidant; about 9.7 to about 12.9% (w/w) hydrocarbon resin; about 1.52 to about 1.68% (w/w) zinc oxide; about 8.7 to about 9.5% (w/w) liquid butadiene acrylonitrile rubber. (NBR); about 4.0 to about 4.4% (w/w) aluminium hydrosilicate; about 5.5 to about 7.5% (w/w) diisononyl phthalate; about 0.66 to about 0.74% (w/w) carbon black; about 1.5 to about 1.7% (w/w) amorphous silica; and about 25.8 to about 38.8% (w/w) magnesium and calcium carbonate. The tape exhibits a good ability to conform to irregular surfaces, good elasticity, good impact resistance, excellent pipe adhesion and good cathodic detachment. The tape is ideally used in conjunction with a primer that improves adhesion between the pipe and the adhesive portion of the tape. | 10-31-2013 |
Vanessa Crespy, Mechanicsburg, OH US
Patent application number | Description | Published |
---|---|---|
20140023625 | BIOLOGICAL EFFECTS OF COMPOSITIONS OF ROSMARINIC ACID - The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject. | 01-23-2014 |
Vanessa Crespy, Vevey CH
Patent application number | Description | Published |
---|---|---|
20100129324 | BIOLOGICAL EFFECTS OF COMPOSITIONS COMPRISING ROSMARINIC ACID - The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject. | 05-27-2010 |
Vanessa Crespy, Dublin, OH US
Patent application number | Description | Published |
---|---|---|
20110280848 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF - The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing chicoric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing chicoric acid and/or derivatives thereof to generate tartaric and/or caffeic acid. | 11-17-2011 |
20120020926 | COMPOSITION COMPRISING CAFTARIC ACID AND/OR DERIVATIVES THEREOF - The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing caftaric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid. | 01-26-2012 |
20120177738 | GREEN TEA EXTRACTS OF IMPROVED BIOAVAILABILITY - The present invention relates to a green tea formulation stabilized by natural antioxidants such as OPC together with vitamin C or vitamin C analogs. The invention also relates to the use of a mixture of OPC and ascorbic acid to increase bioavailability of green tea catechins. It also relates to a food, pharmaceutical or cosmetic composition that contains the stabilized green tea formulation. | 07-12-2012 |
Vanessa Cull, Western Australia AU
Patent application number | Description | Published |
---|---|---|
20090011405 | Modulating Screening Thresholds for N-Hybrid Screening - The present invention provides improved N-hybrid assays. In particular, the present invention provides an improved reverse N-hybrid assay comprising modulating the amount of a substrate of a reporter gene and/or the amount of a reporter gene thereby enhancing cell death in the absence of a peptide inhibitor of a DNA-protein or protein-protein interaction and/or enhancing cell survival in the presence of a peptide inhibitor of a DNA-protein or protein-protein interaction. Furthermore, the present invention provides an improved forward N-hybrid assay comprising modulating the amount of a reporter gene thereby enhancing cell death in the absence of a heterologous peptide or protein capable of binding to the DNA or protein in a cell and enhancing cell survival in the presence of a heterologous peptide or protein capable of binding to the DNA or protein in a cell. | 01-08-2009 |
Vanessa De Moura Sa Rocha, Sao Paulo - Sp BR
Patent application number | Description | Published |
---|---|---|
20130012577 | PROCESS TO OBTAIN A STANDARDIZED EXTRACT OF QUERCETIN AND 3-O-METHYLQUERCETIN FROM INFLORESCENCES OF MACELA-DO-CAMPO, A COSMETIC, PHARMACEUTICAL AND VETERINARY COMPOSITION CONTAINING EXTRACT OF MACELA-DO-CAMPO, THE USE OF THIS EXTRACT AND THE METHOD OF APPLICATION OF THE AFORESAID EXTRACT - It describes an extraction process for obtaining a standardized extract of quercetin and 3-0-methylquercetin from inflorescences of macela-do-campo ( | 01-10-2013 |
Vanessa De Moura Sá Rocha, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20110097290 | Cosmetic Composition Comprising Siliconed Sapucainha Ester and a Cosmetic Product Comprising Said Composition - The present invention relates to a cosmetic composition comprising siliconed sapucainha ester, compound which can be used as a cosmetic excipient replacing silicones for several applications. | 04-28-2011 |
20120328547 | Cosmetic Composition Comprising Siliconed Sapucainha Ester and a Cosmetic Product Comprising Said Composition - The present invention relates to a cosmetic composition comprising siliconed sapucainha ester, compound which can be used as a cosmetic excipient replacing silicones for several applications. | 12-27-2012 |
Vanessa De Moura Sá Rocha, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20110097290 | Cosmetic Composition Comprising Siliconed Sapucainha Ester and a Cosmetic Product Comprising Said Composition - The present invention relates to a cosmetic composition comprising siliconed sapucainha ester, compound which can be used as a cosmetic excipient replacing silicones for several applications. | 04-28-2011 |
20120328547 | Cosmetic Composition Comprising Siliconed Sapucainha Ester and a Cosmetic Product Comprising Said Composition - The present invention relates to a cosmetic composition comprising siliconed sapucainha ester, compound which can be used as a cosmetic excipient replacing silicones for several applications. | 12-27-2012 |
Vanessa Desha, West Palm Beach, FL US
Vanessa Doree, Palaiseau FR
Patent application number | Description | Published |
---|---|---|
20090073714 | AUTOMOTIVE LAMP PROVIDED WITH A BULB LOCKED TO THE CAP OF THE LAMP - An automotive lamp, comprising a translucent bulb ( | 03-19-2009 |
20110228563 | REINFORCEMENT DEVICE, LIGHTING DEVICE SOCKET, LIGHTING DEVICE ASEMBLY AND VEHICLE - The invention relates to a reinforcement device ( | 09-22-2011 |
Vanessa Dreuillault, Paris FR
Patent application number | Description | Published |
---|---|---|
20100082257 | METHODS AND SYSTEMS FOR ACOUSTICALLY MONITORING FORMATIONS - Methods and systems for acoustically determining reservoir parameters of subterranean formations. A tool comprising a plurality of acoustic sources and configured for acoustic measurements is deployed within a wellhole. Acquired acoustic data are processed and utilized for deriving key parameters for the formations. | 04-01-2010 |
Vanessa Duffet, Joinville-Le-Pont FR
Patent application number | Description | Published |
---|---|---|
20110256192 | PHOTOPROTECTIVE COMPOSITION CONTAINING AN UNMODIFIED GELLING STARCH AND POLYAMIDE PARTICLES - The present invention relates to a composition intended for protecting the skin and/or hair against ultraviolet radiation, characterized by the fact that it comprises, in a cosmetically acceptable support containing at least one aqueous phase, at least: (a) a photoprotective system capable of screening out UV radiation; (b) at least one gelling starch that is not modified by a chemical or physical process; and (c) polyamide particles, in particular polyamide PA-12 or polyamide PA-6 particles. The present invention also relates to the use of the combination of at least one gelling starch that is not modified by a chemical or physical process and polyamide particles in a composition comprising, in a cosmetically acceptable support comprising at least one aqueous phase, at least one photoprotective system capable of screening out UV radiation, for the purpose of improving the cosmetic properties after application, especially the non-tacky effect, non-greasy effect, non-shiny effect and/or the absence of residual film. | 10-20-2011 |
20140287005 | PHOTOPROTECTIVE COMPOSITION CONTAINING AN UNMODIFIED GELLING STARCH AND POLYAMIDE PARTICLES - The present invention relates to a composition intended for protecting the skin and/or hair against ultraviolet radiation, characterized by the fact that it comprises, in a cosmetically acceptable support containing at least one aqueous phase, at least: (a) a photoprotective system capable of screening out UV radiation; (b) at least one gelling starch that is not modified by a chemical or physical process; and (c) polyamide particles, in particular polyamide PA-12 or polyamide PA-6 particles. The present invention also relates to the use of the combination of at least one gelling starch that is not modified by a chemical or physical process and polyamide particles in a composition comprising, in a cosmetically acceptable support comprising at least one aqueous phase, at least one photoprotective system capable of screening out UV radiation, for the purpose of improving the cosmetic properties after application, especially the non-tacky effect, non-greasy effect, non-shiny effect and/or the absence of residual film. | 09-25-2014 |
Vanessa Escuret, Lyon FR
Patent application number | Description | Published |
---|---|---|
20090004137 | Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv - The invention relates to the use of an uridine derivative of formula (I); wherein —R | 01-01-2009 |
Vanessa Feliberti, Sammamish, WA US
Patent application number | Description | Published |
---|---|---|
20090319780 | ESTABLISHING SECURE DATA TRANSMISSION USING UNSECURED E-MAIL - In one embodiment, a host entity may create a trusted connection with a guest entity. The host entity may encrypt a trusted connection invitation for an external guest entity using a proof of possession of a trusted token for the external guest entity. The host entity may transmit the encrypted trusted connection invitation to the external guest entity. A guest entity may decrypt the trusted token, and then use the proof of possession to decrypt the trusted connection invitation. | 12-24-2009 |
20140171129 | LOCATION CONTEXT, SUPPLEMENTAL INFORMATION, AND SUGGESTIONS FOR MEETING LOCATIONS - Enhanced input field features and techniques for displaying and resolving location information in meeting items are provided. In response to a user's interaction with a place name displayed in the location field of a user interface for a meeting item, up to date information is retrieved about the location associated with the place name from a web service and displayed. The display can include a map image tile. In addition to enabling the displaying of up to date information, during creation of the meeting item, the location input field of a meeting item can present location suggestions from within the location input field, for example, as a drop-down listing of possible locations. The suggestions for completing a user's input text string to the location input field can be obtained from sources such as a web service, a mailbox, a managed database/directory service, a history cache/database or a combination thereof. | 06-19-2014 |
Vanessa Fever, Drusenheim FR
Patent application number | Description | Published |
---|---|---|
20110136927 | FLAME RETARDANT THERMOPLASTIC ELASTOMERS - A thermoplastic elastomer (TPE) is disclosed which is flame retardant and essentially halogen-free. An embodiment also includes expandable graphite filler to further provide fire protection. | 06-09-2011 |
Vanessa Frias-Martinez, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110214161 | METHODS, MEDIA, AND SYSTEMS FOR SECURING COMMUNICATIONS BETWEEN A FIRST NODE AND A SECOND NODE - Methods, media, and systems for securing communications between a first node and a second node are provided. In some embodiments, methods for securing communication between a first node and a second node are provided. The methods comprising: receiving at least one model of behavior of the second node at the first node; and authorizing the first node to receive traffic from the second node based on the difference between the at least one model of behavior of the second node and at least one model of behavior of the first node. | 09-01-2011 |
Vanessa Gahier, Jouy Le Moutier FR
Patent application number | Description | Published |
---|---|---|
20110005273 | METHOD FOR PRODUCING A FLOW RICH IN METHANE AND A FLOW RICH IN C2+ HYDROCARBONS, AND ASSOCIATED INSTALLATION - This method comprises cooling the supply flow in a first heat exchanger, separation in a first separation flask in order to produce a light upper flow and a heavy lower flow and dividing the light upper flow into a supply fraction of a dynamic pressure reduction turbine and a supply fraction of a first distillation column. | 01-13-2011 |
20130340473 | METHOD FOR PRODUCING A C3+ HYDROCARBON-RICH FRACTION AND A METHANE- AND ETHANE-RICH STREAM FROM A HYDROCARBON-RICH FEED STREAM, AND RELATED FACILITY - The method according to the invention comprises the separation of a feed stream ( | 12-26-2013 |
20140290307 | METHOD FOR PRODUCING A METHANE-RICH STREAM AND A C2+ HYDROCARBON-RICH STREAM, AND ASSOCIATED EQUIPMENT - This method comprises a separation of a feed stream ( | 10-02-2014 |
Vanessa Gonnot, Suce En Erdre FR
Patent application number | Description | Published |
---|---|---|
20100105897 | NOVEL QUINUCLIDINE DERIVATIVE USEFUL IN THE PREPARATION OF MEQUITAZINE - The invention relates to a 1-aza-bicyclo[2.2.2]oct-2-en-3-ylmethyl acetate of the formula (I), wherein said compound is useful as a synthesis intermediate for the production of mequitazine. | 04-29-2010 |
20120088917 | NEW QUINUCLIDINE DERIVATIVE USEFUL IN THE PREPARATION OF MEQUITAZINE - The invention relates to a 1-aza-bicyclo [2.2.2] oct-2-en-3-ylmethyl acetate of the formula (I), wherein said compound is useful as a synthesis intermediate for the production of mequitazine. | 04-12-2012 |
Vanessa Green, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20140268563 | METHOD AND APPARATUS FOR CONTROLLING HEAT IN POWER CONVERSION SYSTEMS - A power module includes a housing and an AC/DC converter within the housing. The AC/DC converter is configured to convert an AC input signal into a DC output signal. The power module also includes an actuated heat removal device. The actuated heat removal device is configured to remove heat produced by the AC/DC converter from the housing. | 09-18-2014 |
20140268564 | METHOD AND APPARATUS FOR CONTROLLING HEAT IN POWER CONVERSION SYSTEMS - A power conversion module, such as a power adapter, includes a heat removal system such as an active heat removal system, a passive heat removal system or a hybrid heat removal system. A small-size power conversion module having a heat removal system is described. | 09-18-2014 |
Vanessa Harpin, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080233570 | METHODS FOR IDENTIFICATION OF SEPSIS-CAUSING BACTERIA - The present invention provides compositions, kits and methods for rapid identification and quantification of sepsis-causing bacteria by molecular mass and base composition analysis. | 09-25-2008 |
Vanessa Ho-Kon-Tiat, Talance Cedex FR
Patent application number | Description | Published |
---|---|---|
20120138849 | COMPOSITE MATERIAL FOR STORING HEAT ENERGY AT HIGH TEMPERATURES - Composite material for storing heat energy at high temperatures (225° C. to 488° C.) formed by a porous carbon structure at least partially filled with LiOH/KOH, wherein a large amount of heat energy may be stored or released very quickly. The carbon structure is characterised by a high volumetric thermal conductivity, a low density, a highly interconnected porosity and a relatively high modulus of elasticity. The significant properties of LiOH/KOH mixtures are: a large amount of energy involved in full melting/crystallisation, a fairly low relative volume expansion upon melting and fairly low subcooling. The main advantages of the resulting composites are a very high energy density, a relatively low volume expansion, highly enhanced heat transfer, thermoadaptability, stability and insignificant hysteresis. | 06-07-2012 |
Vanessa Honeyghan, Cranston, RI US
Patent application number | Description | Published |
---|---|---|
20110220674 | DRINKING VESSEL WITH ATMOSPHERIC ASSIST VALVE - Drinking vessels have an elongated container body joined with a closure body having a dispensing orifice and a vent orifice, each in fluid-passing communication with the interior of the container body. A closure arm is rotatably mounted near one end of it and has at least two sealing members spaced from each other along the length of the closure arm, one of the sealing members opening and closing the vent opening while another of the sealing members opens and closes the vent opening while another of the sealing members opens and closes the dispensing orifice when the closure arm is rotated between its open and closed positions. At least the sealing member for the vent orifice has an elastomeric surface that sealingly engages a surface at the vent orifice when at the closed position. An elastomeric surface can instead or in addition be provided at the vent orifice surface. Elastomeric surfaces can be similarly provided at one or both opposing surfaces of the dispensing area. The elongated container body exterior can have outer surface elongated cylindrical cross-sections that vary from circular to polygonal, and a fluid-flow interrupter can be provided within the container. | 09-15-2011 |
Vanessa Hsei, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090098147 | Antibody fragment-polymer conjugates and uses of same - Described are conjugates formed by an antibody fragment covalently attached to a non-proteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugates exhibit substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment. Also described are conjugates directed against human vascular endothelial growth factor (VEGF), human p185 receptor-like tyrosine kinase (HER2), human CD20, human CD18, human CD11a, human IgE, human apoptosis receptor-2 (Apo-2), human tumor necrosis factor-α (TNF-α), human tissue factor (TF), human α | 04-16-2009 |
20110104185 | ANTIBODY FRAGMENT-POLYMER CONJUGATES AND USES OF SAME - Described are conjugates formed by an antibody fragment covalently attached to a non-proteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugates exhibit substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment. Also described are conjugates directed against human vascular endothelial growth factor (VEGF), human p185 receptor-like tyrosine kinase (HER2), human CD20, human CD18, human CD11a, human IgE, human apoptosis receptor-2 (Apo-2), human tumor necrosis factor-α (TNF-α), human tissue factor (TF), human α | 05-05-2011 |
20130084302 | Methods of binding TNF-alpha using Anti-TNF-alpha antibody fragment-polymer conjugates - Described are conjugates formed by an antibody fragment covalently attached to a nonproteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugates exhibit substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment. Also described are conjugates directed against human vascular endothelial growth factor (VEGF), human p185 receptor-like tyrosine kinase (HER2), human CD20, human CD18, human CD11a, human IgE, human apoptosis receptor-2 (Apo-2), human tumor necrosis factor-α (TNF-α), human tissue factor (TF), human α | 04-04-2013 |
Vanessa Kubryk, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20100136293 | Curved structural part made of composite material and a process for manufacturing such a part - The disclosed embodiments concern a curved structural part composed of a composite material with reinforced, continuous fibers whose cross section includes at least two wings, with said fibers extending from one wing to the other, with said structural part having a variation in the width of its section parallel to the local radius of curvature. The structural element that results from assembling the parts in the disclosed embodiments therefore has local widening of the section at the connections between the parts constituting a structural element, such as an aircraft fuselage frame, and widening at the connection with the floor profiles, if such a profile is used to make an aircraft fuselage structure. The disclosed embodiments also concern a process for manufacturing such a part, as well as a device for advantageously implementing such a process. | 06-03-2010 |
20120098155 | CURVED STRUCTURAL PART MADE OF COMPOSITE MATERIAL AND A PROCESS FOR MANUFACTURING SUCH A PART - A process for manufacturing a curved structural part includes fabricating a mold of the curved structural part having at least two faces that form a male mold section between a minimum radius of curvature of the curved structural part and another radius of curvature belonging to one of the two faces, preparing a stack of multidirectional fibers of one or more fiber plies oriented ±α or 90° in relation to a longitudinal direction of the curved structural part, cutting a first multidirectional strip in the stack extending longitudinally and having a width at least equal to a maximum width of the curved structural part, applying the first multidirectional strip over the mold to gradually conform the first multidirectional strip to the mold, applying the first multidirectional strip on the face having the minimum radius of curvature, and pressing and tightening the first multidirectional strip over the other faces. | 04-26-2012 |
Vanessa Larsen, Manly AU
Patent application number | Description | Published |
---|---|---|
20100060448 | BABY MONITORING APPARATUS - The present invention provides a baby monitoring apparatus comprising a crib mobile unit having a baby monitor unit and a remote control unit, wherein the baby monitoring apparatus is adapted and configured to allow a two-way wireless communication between the remote control unit and the crib mobile unit. | 03-11-2010 |
Vanessa Lebarbier, Richland, WA US
Patent application number | Description | Published |
---|---|---|
20110152582 | Multihydric Compound Dehydration Systems, Catalyst Compositions, and Methods - The present disclosure relates to facilities, systems, methods and/or catalysts for use in chemical production. In particular, the disclosure provides innovations relating to dehydration of multihydric compounds such as glycerol to form acrolein. Some of these innovations include continuous reaction systems as well as system parameters that allow for long term production. | 06-23-2011 |
20130253227 | Multihydric Compound Dehydration Systems, Catalyst Compositions, and Methods - The present disclosure relates to facilities, systems, methods and/or catalysts for use in chemical production. In particular, the disclosure provides innovations relating to dehydration of multihydric compounds such as glycerol to form acrolein. Some of these innovations include continuous reaction systems as well as system parameters that allow for long term production. | 09-26-2013 |
Vanessa Lilligren, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140311635 | Reversible Satchel and Method of Wearing Same - A personal belongings bag designed to be worn over a user's shoulder and rest on an opposite hip is disclosed. A preferred embodiment has a thin profile and is pliable to conform to a user's body and be worn under a user's coat, thereby deterring purse snatching. A reinforced mesh strap has a similar anti-slashing purpose. The bag also has an adjustable strap provided by a plurality of snap fasteners. | 10-23-2014 |
Vanessa Lopez, Dublin IE
Patent application number | Description | Published |
---|---|---|
20140324915 | GUARANTEEING ANONYMITY OF LINKED DATA GRAPHS - A method, system and computer program product for transforming a Linked Data graph into a corresponding anonymous Linked Data graph, in which semantics is preserved and links can be followed to expand the anonymous graph up to r times without breaching anonymity (i.e., anonymity under r-dereferenceability). Anonymizing a Linked Data graph under r-dereferenceability provides privacy guarantees of k-anonymity or l-diversity variants, while taking into account and preserving the rich semantics of the graph. | 10-30-2014 |
20140325666 | GUARANTEEING ANONYMITY OF LINKED DATA GRAPHS - A system and computer program product for transforming a Linked Data graph into a corresponding anonymous Linked Data graph, in which semantics is preserved and links can be followed to expand the anonymous graph up to r times without breaching anonymity (i.e., anonymity under r-dereferenceability). Anonymizing a Linked Data graph under r-dereferenceability provides privacy guarantees of k-anonymity or l-diversity variants, while taking into account and preserving the rich semantics of the graph. | 10-30-2014 |
Vanessa Lopez-Marrero, Yorktown Heights, NY US
Patent application number | Description | Published |
---|---|---|
20110040529 | Methods and Techniques for Creating and Visualizing Thermal Zones - Techniques for using air flow analysis to model thermal zones are provided. In one aspect, a method for modeling thermal zones in a space, e.g., in a data center, includes the following steps. A graphical representation of the space is provided. At least one domain is defined in the space for modeling. A mesh is created in the domain by sub-dividing the domain into a set of discrete sub-domains that interconnect a plurality of nodes. Air flow sources and sinks are identified in the domain. Air flow measurements are obtained from one or more of the air flow sources and sinks. An air flow velocity vector at a center of each sub-domain is determined using the air flow measurements obtained from the air flow sources and sinks. Each velocity vector is traced to one of the air flow sources, wherein a combination of the traces to a given one of the air flow sources represents a thermal zone in the space. | 02-17-2011 |
20120203516 | Techniques for Determining Physical Zones of Influence - Techniques for analyzing flow of a quantity in a given domain are provided. In one aspect, a method for modeling regions in a domain affected by a flow of a quantity is provided which includes the following steps. A physical representation of the domain is provided. A grid that contains a plurality of grid-points in the domain is created. Sources are identified in the domain. Given a vector field that defines a direction of flow of the quantity within the domain, a boundary value problem is defined for each of one or more of the sources identified in the domain. Each of the boundary value problems is solved numerically to obtain a solution for the boundary value problems at each of the grid-points. The boundary value problem solutions are post-processed to model the regions affected by the flow of the quantity on the physical representation of the domain. | 08-09-2012 |
20130103214 | Provisioning Aggregate Computational Workloads And Air Conditioning Unit Configurations To Optimize Utility Of Air Conditioning Units And Processing Resources Within A Data Center - Methods, apparatuses, and computer program products for provisioning aggregate computational workloads and air conditioning unit configurations to optimize utility of air conditioning units and processing resources within a data center are provided. Embodiments include for each air conditioning unit within the data center, determining a thermal zone generated by the air conditioning unit; for a given aggregate computational workload, identifying a plurality of computational workload configurations, each computational workload configuration indicating spatial assignments of the aggregate computational workload among a plurality of processing resources within the data center; for each computational workload configuration, calculating a total minimum energy consumption of the air conditioning units and the processing resources; and selecting the computational workload configuration with the lowest total minimum energy consumption and the determined lowest power air conditioning unit configuration corresponding with the selected computational workload configuration. | 04-25-2013 |
20130103218 | PROVISIONING AGGREGATE COMPUTATIONAL WORKLOADS AND AIR CONDITIONING UNIT CONFIGURATIONS TO OPTIMIZE UTILITY OF AIR CONDITIONING UNITS AND PROCESSING RESOURCES WITHIN A DATA CENTER - Methods, apparatuses, and computer program products for provisioning aggregate computational workloads and air conditioning unit configurations to optimize utility of air conditioning units and processing resources within a data center are provided. Embodiments include for each air conditioning unit within the data center, determining a thermal zone generated by the air conditioning unit; for a given aggregate computational workload, identifying a plurality of computational workload configurations, each computational workload configuration indicating spatial assignments of the aggregate computational workload among a plurality of processing resources within the data center; for each computational workload configuration, calculating a total minimum energy consumption of the air conditioning units and the processing resources; and selecting the computational workload configuration with the lowest total minimum energy consumption and the determined lowest power air conditioning unit configuration corresponding with the selected computational workload configuration. | 04-25-2013 |
Vanessa Mengeling, Massy FR
Patent application number | Description | Published |
---|---|---|
20120039738 | METHOD FOR MANUFACTURING AN ASSEMBLY INCLUDING A PLURALITY OF BLADES MOUNTED IN A PLATFORM - A method of manufacturing an assembly, including a plurality of blades mounted in a platform preparing a mixture of metal powder and thermoplastic binder, includes manufacturing the blades separately from the platform, and finishing the blades after the manufacturing. The method also includes injecting the mixture into a mold to obtain a platform blank, removing the binder from the platform blank prior to assembling the finished blades with the blank, inserting one end of the finished blades into a housing formed in the platform blank in order to assemble the assembly, and sintering the assembly comprising the platform blank and the finished blades to unify the assembly. | 02-16-2012 |
Vanessa Moby, Dombasle FR
Patent application number | Description | Published |
---|---|---|
20110151564 | METHOD FOR PROLIFERATION OF CELLS ON POLYELECTROLYTE MULTILAYER FILMS AND USE THEREOF, PARTICULARLY FOR THE PREPARATION OF CELLULAR BIOMATERIALS - The invention relates to the use of a unit including a substrate and polyelectrolyte multilayer films deposited thereon in order to: carry out a method involving the proliferation of initial stem or differentiated cells that are brought into contact with the unit; and cover the unit with confluent viable adherent cells resulting from the proliferation of the initial cells, the cover being obtained at the end of a period of no more than one month, such as 14 days, 11 days or, in particular, 7 days, after the initial cells are brought into contact with the unit. | 06-23-2011 |
Vanessa Mueller, Weinheim DE
Patent application number | Description | Published |
---|---|---|
20130342580 | VIRTUAL BUSINESS DESKTOP FOR ARRANGEMENT OF OBJECTS - Methods and apparatus, including computer program products, are provided for user interfaces. In one aspect, there is provided a method. The method may include generating a virtual desktop including a plurality of objects organized in accordance with at least one of a theme and a structure; providing a navigation pane on the virtual desktop to navigate through the plurality of objects; and providing a controller to enable a multi-level zoom on at least one of the plurality of objects on the virtual desktop. Related systems, methods, and articles of manufacture are also disclosed. | 12-26-2013 |
Vanessa Nancy-Portebois, Les Pavillons-Sous-Bois FR
Patent application number | Description | Published |
---|---|---|
20110166078 | OLIGOSACCHARIDE COMPOUNDS FOR USE IN MOBILISING STEM CELLS - A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting the mobilisation of stem cells, in particular hematopoietic stem cells. | 07-07-2011 |
20120316132 | PHARMACEUTICAL ORAL DOSAGE FORM CONTAINING A SYNTHETIC OLIGOSACCHARIDE - The present invention concerns a pharmaceutical formulation intended for oral administration containing a synthetic oligosaccharides containing one to 18 monosaccharide units and having a therapeutical activity or a pharmaceutically acceptable additions salt or solvate thereof wherein the formulation contains: a) the synthetic oligosaccharide (A) in an amount of up to 5% by weight of the total weight of the formulation, advantageously up to 1% by weight of the total weight of the formulation, b), a lipophilic phase (B) consisting of triglyceride of fatty acids in an amount of 50 to 80% by weight of the total weight of the formulation, advantageously of 50 to 70% by weight of the total weight of the formulation, c) at least one lipophilic surfactant (C) with HLB below 7 consisting of partial esters of polyol and fatty acids in an amount of 10 to 30% by weight of the total weight of the formulation, advantageously of 15 to 30% by weight of the total weight of the formulation, d) at least one hydrophilic surfactant (D) with HLB above 7 in an amount of up to 20% by weight of the total weight of the formulation, advantageously up to 15% by weight of the total weight of the formulation, e) optionally, at least one hydrophilic solvent (E) in an amount of up to 15% by weight of the total weight of the formulation, advantageously up to 10% by weight of the total weight of the formulation, (F) between 0 and 30% by weight of the total weight of the formulation of a chemical and/or physical stabilization agent (F), advantageously between 0 and 20% by weight of the total weight of the formulation, wherein when the formulation is in a form of a reverse emulsion or microemulsion and contains at least one hydrophilic solvent (E), the physical stabilization agent is present and is silicon dioxide. | 12-13-2012 |
Vanessa Paulisch, Munchen DE
Patent application number | Description | Published |
---|---|---|
20130013638 | Intelligent Search - A method includes loading at least two databases in a server, a first database including smart tags referred to as stags and a second database including searchable content, enabling a user to generate one or more searches using the stags, each of the stags including at least one or more what components, an equal number of or a single where component, a single how component, several where components and a single how component, or several how components that are linked with another how component, and descriptive metadata and usage data, converting the stags with an interpreting engine into a search query, maintaining in a stag management engine the stag and usage data, generating data from third party databases to rank stags in a graphical user interface, and generating a list of matching results of database records and stags depending on a user selection. | 01-10-2013 |
Vanessa Pellegrinelli, Juvisy Sur Orge FR
Patent application number | Description | Published |
---|---|---|
20130183706 | Method for Culturing Adipocytes - The present invention relates to a method for culturing adipocytes, in which a homogeneous population of mature adipocytes isolated from adipose tissue is cultured on a three-dimensional culture substrate. | 07-18-2013 |
Vanessa Picron, Pontoise FR
Patent application number | Description | Published |
---|---|---|
20090259380 | METHOD FOR MANAGING A TORQUE APPLIED TO AN OUTPUT SHAFT OF A COMBUSTION ENGINE WHEN ONE COMBUSTION CHAMBER IS DEACTIVATED, AND CORRESPONDING MANAGEMENT SYSTEM - A method for managing a torque applied to an output shaft of a combustion engine, the combustion engine including combustion chambers, in each of which there is mounted a piston connected to the output shaft in order to apply a torque to it, the output shaft being connected to a rotary machine associated with a management member. The method involves detecting conditions of deactivation of one combustion chamber and controlling the rotary machine so as to apply to the output shaft, prior to the deactivation of one combustion chamber, a compensating torque which tends to cause a resultant torque applied to the output shaft to tend towards a deactivation torque applied by the combustion engine to the output shaft after deactivation of the combustion chamber. | 10-15-2009 |
20090287399 | METHOD AND DEVICE FOR CONTROLLING A COMBUSTION ENGINE DURING A TEMPORARY STOPPAGE - A method for controlling, during temporary stoppage, a four-stroke combustion engine including a block delimiting cylinders which define combustion chambers equipped with pistons into which opens an intake pipe and an exhaust pipe, both provided with valves that can move between open and closed positions. The method involves detecting conditions of a temporary stoppage of the engine and commanding the exhaust valves to be kept in the closed position once the engine has gone through an intake phase during the last engine cycle prior to the stoppage. | 11-19-2009 |
Vanessa Pizzaballa, Fara Gera D'Adda (bg) IT
Patent application number | Description | Published |
---|---|---|
20120264180 | PROCESS FOR THE BIOLOGIC TREATMENT OF ORGANIC WASTES AND PLANT THEREFOR - Process for the biological treatment of organic wastes, includes a first anaerobic digestion phase and a second aerobic digestion phase in succession, a respective filtration phase of the solid substance being provided between the two digestion phases, a separation phase of the biogas released in the anaerobic digestion phase and a nitrogen recovery phase from the exhaust gases rich in ammoniac substances separated from the aerobic digestion phase. The solid substance coming from each of the filtration phases is separately returned to the respective digestion phase, while the liquid phase coming from the filtration phase downstream of the anaerobic digestion phase is sent to aerobic phase. In the nitrogen recovery phase the gaseous current consisting of exhaust gases rich in ammoniac substances is treated with a solution of carbonic acid supplied in countercurrent in a first gas/liquid contactor to obtain a mixture of nitrogen salts (ammonium bicarbonate, ammonium carbonate, etc.). | 10-18-2012 |
Vanessa Ragaglia, Newtown Square, PA US
Patent application number | Description | Published |
---|---|---|
20090053183 | Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 02-26-2009 |
20120121555 | Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 05-17-2012 |
20120148544 | Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 06-14-2012 |
20120156192 | Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 06-21-2012 |
20130190257 | Methods of Ganglioside Production - The invention provides methods for production of gangliosides, e.g., GM1, from cells in culture using, for example, bone marrow cells and neuroblastoma cells. Methods include the treatment of cells with neural induction media and chloroquine, or chloroquine alone in the case of, e.g., human bone marrow cells, neuraminidase or glucosamine, to induce the production of gangliosides, e.g., GM1, in the cells. Also provided are methods of long-term, high density culturing of cells without passaging to produce gangliosides, e.g., GM1. Methods of quantifying gangliosides, e.g., GM1 in cell culture are also provided. | 07-25-2013 |
20130259837 | Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 10-03-2013 |
20130261067 | Methods of Ganglioside Production - The invention provides methods for production of gangliosides, e.g., GM1, from cells in culture using, for example, bone marrow cells and neuroblastoma cells. Methods include the treatment of cells with neural induction media and chloroquine, or chloroquine alone in the case of, e.g., human bone marrow cells, neuraminidase or glucosamine, to induce the production of gangliosides, e.g., GM1, in the cells. Also provided are methods of long-term, high density culturing of cells without passaging to produce gangliosides, e.g., GM1. Methods of quantifying gangliosides, e.g., GM1 in cell culture are also provided. | 10-03-2013 |
20130266542 | Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 10-10-2013 |
20140086884 | TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO - The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 03-27-2014 |
20140099329 | TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO - The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 04-10-2014 |
20150025234 | GANGLIOSIDE COMPOSITIONS - The invention provides novel gangliosides and mixtures of novel gangliosides, and drug products containing the same. The invention also provides cells induced to over-express one or more gangliosides. The invention further provides methods for production of gangliosides, e.g., GM1, from cells in culture using, for example, bone marrow cells and neuroblastoma cells. Methods include the treatment of cells with neural induction media and chloroquine, or chloroquine alone in the case of, e.g., human bone marrow cells, neuraminidase or glucosamine, to induce the production of gangliosides, e.g., GM1, in the cells. Also provided are methods of long-term, high density culturing of cells without passaging to produce gangliosides, e.g., GM1. Methods of quantifying gangliosides, e.g., GM1 in cell culture are also provided. | 01-22-2015 |
Vanessa Ragaglia, Newton Square, PA US
Patent application number | Description | Published |
---|---|---|
20120003188 | Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro - The invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (CF-SC). For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. | 01-05-2012 |
Vanessa Ruta, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090075394 | Voltage Sensor Domains of Voltage-Dependent Ion Channel Proteins and Uses Thereof - A composition of matter suitable for use in identifying chemical compounds that bind to voltage-dependent ion channel proteins, the composition comprising a screening protein that comprises an ion channel voltage sensor domain of the ion channel protein immobilized on a solid support. | 03-19-2009 |
20110159599 | Voltage Sensor Domains of Voltage-Dependent Ion Channel Proteins and Uses Thereof - A composition of matter suitable for use in identifying chemical compounds that bind to voltage-dependent ion channel proteins, the composition comprising a screening protein that comprises an ion channel voltage sensor domain of the ion channel protein immobilized on a solid support. | 06-30-2011 |
Vanessa Schelkens, Heverlee BE
Patent application number | Description | Published |
---|---|---|
20110246259 | METHOD OF EFFICIENTLY MANAGING ENERGY - A method is provided for managing energy. The method comprises collecting information relating to amounts of energy stored by a plurality of members of a group, and relating to energy requirements of the members. The method further comprises determining a price for distributing energy to a non-member of the group, determining whether to supply energy stored by the members to the non-member at the determined price, and issuing instructions to distribute energy upon determining that energy stored by the plurality of members should be supplied to the non-member. | 10-06-2011 |
20120243750 | METHOD, APPARATUS AND SYSTEM FOR OUTPUTTING A GROUP OF IMAGES - There is described an apparatus for outputting a group of images for display, the group being taken from a plurality of images, each image in the plurality of images having a face located therein, the apparatus comprising a processor configured to: retrieve a set of images from a storage medium, the set of images containing at least the plurality of images from which the group of images to be displayed is selected; identify the face in each of the plurality of images; identify variable features on the face in each of the plurality of images; establish the group of images in accordance with a measure of the dissimilarity between the variable features in the plurality of images; and output the group of images for display. | 09-27-2012 |
20120251082 | METHOD, APPARATUS AND SYSTEM FOR GENERATING MEDIA CONTENT - A method of generating media content is described which comprises capturing still or moving image content items at a capture device and uploading the captured image content items and image content metadata indicating a time of capture of each of the image content items to a network. A playback log indicating playback times of audio content items listened to by the user of the capture device is stored. One or more of the captured image content items is correlated with one or more portions of the playback log based on the time of capture indicated by the metadata relating to the one or more captured content items and the playback times indicated by the playback log. A media output is generated as a collection of a plurality of the captured image content items stored at the network accompanied by audio content related to the portion of the playback log which is correlated with the captured image content items in the collection. In this way, a media output can be generated at a network, such as a cloud network, from user generated image content and commercial audio content which the user who captured the image content was listening to at the time the image content was captured. | 10-04-2012 |
Vanessa Silva Segarra, Liberty Township, OH US
Patent application number | Description | Published |
---|---|---|
20130158491 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE OR ODOR CONTROL COMPOSITION - An absorbent article selected from a sanitary napkin, an incontinence pad end a panty liner, comprises a topsheet layer, a backsheet layer, optionally one or more intermediate layers enclosed between the topsheet and the backstreet a fastening adhesive applied on said backsheet garment lacing surface and a liquid fragrance or odor control composition applied on or within a layer of said absorbent article. The fastening adhesive and the liquid fragrance or odor control composition axe applied in patterns which do not overlap for more than | 06-20-2013 |
Vanessa Stenchly, Meldorf DE
Patent application number | Description | Published |
---|---|---|
20150040368 | METHOD FOR PRODUCING STRUCTURED OPTICAL COMPONENTS - The method according to the invention is used for producing optical components, in particular covers for encapsulating micro-systems, wherein at least one reinforcing element, which is produced before being arranged, is arranged on a first substrate, as a result of which a stack is produced. This stack is heated after being connected to a second substrate, as a result of which the first substrate is deformed such that at least one region, covered by the reinforcing element, of the first substrate is moved and/or is inclined or the first substrate is brought into contact with the reinforcing element. In an alternative method according to the invention, the reinforcing element is arranged on the second substrate, wherein this stack is then connected to the first substrate. The first substrate is subsequently heated and deformed such that a region of the first substrate is brought into contact with the reinforcing element. | 02-12-2015 |
Vanessa Tolosa, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20130345780 | Conformally Encapsulated Multi-Electrode Arrays With Seamless Insulation - Thin-film multi-electrode arrays (MEA) having one or more electrically conductive beams conformally encapsulated in a seamless block of electrically insulating material, and methods of fabricating such MEAs using reproducible, microfabrication processes. One or more electrically conductive traces are formed on scaffold material that is subsequently removed to suspend the traces over a substrate by support portions of the trace beam in contact with the substrate. By encapsulating the suspended traces, either individually or together, with a single continuous layer of an electrically insulating material, a seamless block of electrically insulating material is formed that conforms to the shape of the trace beam structure, including any trace backings which provide suspension support. Electrical contacts, electrodes, or leads of the traces are exposed from the encapsulated trace beam structure by removing the substrate. | 12-26-2013 |
20140107446 | FLEXIBLE MICROELECTRODE ARRAY WITH INTEGRATED STIFFENING SHANK, AND METHOD OF FABRICATION - A stiffener-reinforced microelectrode array device and fabrication method having a plurality of polymer layers surroundably encapsulating one or more electrodes connected to one or more metal traces so that the one or more electrodes are exposed. A stiffening shank is also integrally embedded in the polymer layers adjacent an insertion end of the device near the electrodes to provide mechanical support during insertion. | 04-17-2014 |
20140262462 | DEPOSITING BULK OR MICRO-SCALE ELECTRODES - Thicker electrodes are provided on microelectronic device using thermo-compression bonding. A thin-film electrical conducting layer forms electrical conduits and bulk depositing provides an electrode layer on the thin-film electrical conducting layer. An insulating polymer layer encapsulates the electrically thin-film electrical conducting layer and the electrode layer. Some of the insulating layer is removed to expose the electrode layer. | 09-18-2014 |
20140277296 | INCORPORATING AN OPTICAL WAVEGUIDE INTO A NEURAL INTERFACE - An optical waveguide integrated into a multielectrode array (MEA) neural interface includes a device body, at least one electrode in the device body, at least one electrically conducting lead coupled to the at least one electrode, at least one optical channel in the device body, and waveguide material in the at least one optical channel. The fabrication of a neural interface device includes the steps of providing a device body, providing at least one electrode in the device body, providing at least one electrically conducting lead coupled to the at least one electrode, providing at least one optical channel in the device body, and providing a waveguide material in the at least one optical channel. | 09-18-2014 |
20140277317 | FLEXIBLE NEURAL INTERFACES WITH INTEGRATED STIFFENING SHANK - A neural interface includes a first dielectric material having at least one first opening for a first electrical conducting material, a first electrical conducting material in the first opening, and at least one first interconnection trace electrical conducting material connected to the first electrical conducting material. A stiffening shank material is located adjacent the first dielectric material, the first electrical conducting material, and the first interconnection trace electrical conducting material. | 09-18-2014 |
Vanessa Van Tran, Tulsa, OK US
Patent application number | Description | Published |
---|---|---|
20120060862 | TOWEL LOOFAH - A bathing device has outlet and inlet sides and defines an enclosure. Outlet and inlet sides are permeable to allow water flow through the enclosure. The enclosure is sized to receive soap and to form an air pocket adjacent to the soap, which may be in the form of a bar, a liquid or a gel. A zipper on the inlet side provides access to the enclosure interior. An absorbent member is located proximate the inlet side of the enclosure. In use, soap is located within the compartment. Water is flowed through the inlet side of the enclosure, through the absorbent member and into the soap compartment for mixing the soap and water. Water and dissolved soap are then delivered through the outlet side. Twisting the enclosure about the soap increases mixing as does squeezing the absorbent material to displace water through the outlet side of the enclosure. | 03-15-2012 |
Vanessa Voskinarian-Berse, Millington, NJ US
Patent application number | Description | Published |
---|---|---|
20110003387 | METHOD OF PRODUCING ERYTHROCYTES WITHOUT FEEDER CELLS - Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place. | 01-06-2011 |
20120148553 | METHODS OF GENERATING NATURAL KILLER CELLS - Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection. | 06-14-2012 |
20120230959 | ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES - Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells. | 09-13-2012 |
20140093488 | TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS - Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. | 04-03-2014 |
20140256042 | METHOD OF PRODUCING ERYTHROCYTES WITHOUT FEEDER CELLS - Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place. | 09-11-2014 |
20150072425 | METHODS OF GENERATING NATURAL KILLER CELLS - Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection. | 03-12-2015 |
Vanessa Wodzinski, Mesa, AZ US
Patent application number | Description | Published |
---|---|---|
20140082090 | Method and System for Scheduling a Communication Session - A system and method for scheduling a future collaborative communication session using a collaborative communication application are disclosed. The system and method allow one or more participants of a collaborative communication session to schedule a future communication session directly from a collaborative communication application. A calendar application, such as an enterprise calendar system, may be integrated with the communication application, such that future meetings can easily be scheduled using the communication application. | 03-20-2014 |